Abstract: According to an aspect of the present disclosure, there is provided a substrate treating apparatus comprising: a vessel part having a substrate treatment region formed therein and including a supply port through which a treating fluid is supplied to the substrate treatment region and an exhaust port through which the treating fluid is exhausted from the substrate treatment region; a fluid supply unit configured to supply the treating fluid to the substrate treatment region; an exhaust unit configured to exhaust the treating fluid from the vessel part. The exhaust unit comprises: a main line connected to the exhaust port; an extension line branched from at least one of first and second nodes of the main line and including at least one of a first orifice or a first check valve to control an exhaust speed; and an auxiliary line branched from a third node of the main line, where an orifice and a check valve are not formed.

Abstract: The present invention relates to an epitope of a thioredoxin-1 (Trx1) antigen and a use thereof, and more particularly, to the epitope, and an antibody or an antigen-binding fragment binding thereto. The epitope region of the human Trx1 antigen confirmed in the present invention may be effectively used in the development of an improved antibody to enhance the binding affinity of an anti-Trx1 antibody. In addition, the improved antibody of the present invention is effective in improvement of performance of a breast cancer diagnosis kit due to excellent binding affinity for Trx1 and very high sensitivity and specificity, compared to a conventional anti-Trx1 antibody. Further, the accuracy and reliability of breast cancer diagnosis may significantly increase because exceptionally high sensitivity and specificity are exhibited by detecting the monoclonal antibody of the present invention, which specifically binds to Trx1, rather than detecting CA15-3, another conventional breast cancer diagnostic biomarker.

Abstract: A skin care device using an RF needle is disclosed. According to an embodiment, a skin contact part having a plurality of needles and a vacuum pressure formation unit for applying a suction force to the skin contact part are included, and thus a needle can be inserted into the skin by pulling the skin with vacuum pressure. Therefore, the skin is pulled with suction so that an equipment contact surface accurately comes into contact with the skin, and thus a needle can be correctly inserted into the inner layer of the skin.

Abstract: Proposed is a complex aqua skin peeling machine which allows for the use of a handpiece to supply hydrogen water to the skin of a user for removal of reactive oxygen species in the user's body.

Abstract: A skin treatment device is provided, which includes a needle frame in which a front end outlet of a needle that penetrates an inside thereof projects toward a front thereof, a rear end inlet of the needle is open to an outside of a rear surface thereof, and a stepped partition wall is provided in a closed shape on the outside of the rear surface thereof; a needle cover having a space portion formed on a rear thereof toward an inside thereof, a needle guide portion formed on a front surface thereof; a contact PCB configured to receive a power that is supplied from a power supply device; and a needle hub having an insertion portion formed in a front thereof toward an inside thereof.

Abstract: The present invention relates to a human antibody specifically binding to an acne-inducing bacterium using phage display technology and a use thereof, and more particularly, an antibody specifically binding to an antigen; a human antibody including the same; phage display technology using the same; and a cosmetic composition and a pharmaceutical composition using the same.

Abstract: A handpiece tip is proposed. The handpiece tip includes a contact part to contact the skin, and a coupling part having a space formed therein and coupled to a handpiece body, wherein the contact part includes a surface, a protruding part provided to protrude on an outer side of the surface and touching the skin, a discharging hole formed on the surface to discharge a therapeutic liquid, and a suctioning hole formed on the surface so as to suction a mixture of dead skin cells and the liquid. According to the disclosure, there are effects in that nutrient solution is injected by way of closely contacting the skin, the layers of dead skin cells are removed, and desired abrasive performance on the skin is realized while minimizing skin damage.

Abstract: The present invention relates to an antibody specifically binding to thioredoxin-1 and a use thereof, and more particularly, to an antibody specifically binding to thioredoxin-1 or an antigen-binding fragment thereof, a nucleic acid molecule(s) encoding a heavy chain and/or a light chain of the antibody or antigen-binding fragment thereof, a recombinant vector including the nucleic acid molecule, host cells, a method of preparing the antibody or antigen-binding fragment thereof, a breast cancer diagnostic kit, and a method of providing information necessary for breast cancer diagnosis.

Abstract: A backlight unit includes a first light guide plate, a second light guide plate disposed over the first light guide plate, and a first wavelength conversion layer disposed between the first light guide plate and the second light guide plate.

Abstract: The present invention relates to an epitope of a thioredoxin-1 (Trx1) antigen and a use thereof, and more particularly, to the epitope, and an antibody or an antigen-binding fragment binding thereto. The epitope region of the human Trx1 antigen confirmed in the present invention may be effectively used in the development of an improved antibody to enhance the binding affinity of an anti-Trx1 antibody. In addition, the improved antibody of the present invention is effective in improvement of performance of a breast cancer diagnosis kit due to excellent binding affinity for Trx1 and very high sensitivity and specificity, compared to a conventional anti-Trx1 antibody. Further, the accuracy and reliability of breast cancer diagnosis may significantly increase because exceptionally high sensitivity and specificity are exhibited by detecting the monoclonal antibody of the present invention, which specifically binds to Trx1, rather than detecting CA15-3, another conventional breast cancer diagnostic biomarker.

Abstract: A backlight unit includes a first optical member. The first optical member includes a protrusion extending from a surface of the first optical member. A mold frame partially surrounds the surface of the first optical member. The protrusion of the first optical member includes a fixing hole. The mold frame includes at least one fixing protrusion configured to be inserted into the fixing hole of the protrusion.

Abstract: The present invention relates to an antibody specifically binding to thioredoxin-1 and a use thereof, and more particularly, to an antibody specifically binding to thioredoxin-1 or an antigen-binding fragment thereof, a nucleic acid molecule(s) encoding a heavy chain and/or a light chain of the antibody or antigen-binding fragment thereof, a recombinant vector including the nucleic acid molecule, host cells, a method of preparing the antibody or antigen-binding fragment thereof, a breast cancer diagnostic kit, and a method of providing information necessary for breast cancer diagnosis.

Abstract: A backlight unit includes a first light guide plate, a second light guide plate disposed over the first light guide plate, and a first wavelength conversion layer disposed between the first light guide plate and the second light guide plate.

Abstract: The present invention relates to a human antibody specifically binding to an acne-inducing bacterium using phage display technology and a use thereof, and more particularly, an antibody specifically binding to an antigen; a human antibody including the same; phage display technology using the same; and a cosmetic composition and a pharmaceutical composition using the same.

Abstract: A skin treatment device is provided, which includes a needle frame in which a front end outlet of a needle that penetrates an inside thereof projects toward a front thereof, a rear end inlet of the needle is open to an outside of a rear surface thereof, and a stepped partition wall is provided in a closed shape on the outside of the rear surface thereof; a needle cover having a space portion formed on a rear thereof toward an inside thereof, a needle guide portion formed on a front surface thereof; a contact PCB configured to receive a power that is supplied from a power supply device; and a needle hub having an insertion portion formed in a front thereof toward an inside thereof.

Abstract: Disclosed is a lactic acid-containing composition for inducing animal ovarian dysfunction, designed to increase meat production by causing ovarian dysfunction within animals. The composition comprises 10 to 90% by weight of lactic acid and 10 to 90% by weight of an adjuvant, having a pH of 1˜5. When locally injected into the ovary, the composition causes the ovarian tissue to lose its function, suppressing the estrus of the animals that thus improve in growth and appetite, with a consequent increase in meat production. Also, because even one injection of the lactic acid-based composition at a small dose can accomplish ovarian dysfunction, no lactic acid is left in the meat as well as the animals. Moreover, the composition, even though administered, does not require a drug-free interval, nor cause an increase in blood lactic acid level, and thus can produce animal products suitable for hormone-free certification.

Abstract: A skin treatment device is provided, which includes a needle frame in which a front end outlet of a needle that penetrates an inside thereof projects toward a front thereof, a rear end inlet of the needle is open to an outside of a rear surface thereof, and a stepped partition wall is provided in a closed shape on the outside of the rear surface thereof; a needle cover having a space portion formed on a rear thereof toward an inside thereof, a needle guide portion formed on a front surface thereof; a contact PCB configured to receive a power that is supplied from a power supply device; and a needle hub having an insertion portion formed in a front thereof toward an inside thereof.

Abstract: Disclosed therein is a tip structure for a skin care apparatus. The tip structure includes a first electrode formed on a substrate mounted on the front end part of a tip case and a second electrode formed on the periphery of the front end part of the tip case so as to provide a wide electrode area. The tip structure for the skin care apparatus, which supplies high frequency energy to the skin through electrodes formed at the front end portion of the tip case, includes: a first electrode formed on the substrate mounted on the front end part of the tip case; and a second electrode formed on a peripheral portion of the front end part of the tip case.

Abstract: Disclosed is a lactic acid-containing composition for inducing animal ovarian dysfunction, designed to increase meat production by causing ovarian dysfunction within animals. The composition comprises 10 to 90% by weight of lactic acid and 10 to 90% by weight of an adjuvant, having a pH of 1˜5. When locally injected into the ovary, the composition causes the ovarian tissue to lose its function, suppressing the estrus of the animals that thus improve in growth and appetite, with a consequent increase in meat production. Also, because even one injection of the lactic acid-based composition at a small dose can accomplish ovarian dysfunction, no lactic acid is left in the meat as well as the animals. Moreover, the composition, even though administered, does not require a drug-free interval, nor cause an increase in blood lactic acid level, and thus can produce animal products suitable for hormone-free certification.

Abstract: An optical sheet includes a base film, a prism pattern formed in a first area of the base film, and a diffusion member formed in a second area of the base film. The prism pattern has a plurality of parallel prisms on a light-exiting surface. The diffusion member includes a plurality of scatter members in the base film to scatter light, or a plurality of irregularly arranged lenses on one or more of the light-incident surface and the light-exiting surface.